Product Information
INSULIN LISPRO 100 UNIT/ML KWIKPEN is a generic product labeled by Eli Lilly and Company, priced at $10.2021 per ML under NDC 00002822259. Its NADAC has been published 306 times since Aug 19, 2020.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002822259
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA020563On Market Since
2/12/2020
Pharmacological Classes
Price Statistics
The NADAC for INSULIN LISPRO 100 UNIT/ML KWIKPEN has been published 306 times since Aug 19, 2020, and over the history we have for it it has declined 39.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.2021 per ML |
|---|---|
| All-time high | $16.9986 (May 12, 2021) |
| All-time low | $10.1603 (Feb 22, 2023) |
| 52-week high | $10.2044 |
| 52-week low | $10.1940 |
| Median price | $10.1959 |
| Average price | $11.8066 |
| Largest weekly change | -40.0% (Jan 12, 2022) |
| Weeks tracked | 306 |
| Tracking since | Aug 19, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INSULIN LISPRO 100 UNIT/ML KWIKPEN?
The current National Average Drug Acquisition Cost (NADAC) for INSULIN LISPRO 100 UNIT/ML KWIKPEN, manufactured by Eli Lilly and Company, is $10.2021 per ML (NDC 00002822259), effective Jun 24, 2026.
How has the price of INSULIN LISPRO 100 UNIT/ML KWIKPEN changed over time?
Over the history we have for it, the NADAC for INSULIN LISPRO 100 UNIT/ML KWIKPEN has declined 39.9%. It has been tracked across 306 weekly CMS publications since Aug 19, 2020.
What are the highest and lowest recorded NADAC prices for INSULIN LISPRO 100 UNIT/ML KWIKPEN?
Since Aug 19, 2020, the NADAC for INSULIN LISPRO 100 UNIT/ML KWIKPEN has ranged from a low of $10.1603 (Feb 22, 2023) to a high of $16.9986 (May 12, 2021), with a median of $10.1959 per ML.
Are there cheaper alternatives to INSULIN LISPRO 100 UNIT/ML KWIKPEN?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, INSULIN LISPRO 100 UNIT/ML VL, is $2.4040 per ML — about 76% below INSULIN LISPRO 100 UNIT/ML KWIKPEN.
Who manufactures INSULIN LISPRO 100 UNIT/ML KWIKPEN?
INSULIN LISPRO 100 UNIT/ML KWIKPEN (NDC 00002822259) is labeled by Eli Lilly and Company, and CMS classifies it as a generic product.
Related Drugs
Same classification